InvestorsHub Logo
icon url

HappyLibrarian

01/22/22 4:18 PM

#437795 RE: Maverick0408 #437788

A buyout using stock in the acquiring company would be best for all concerned. Those who want to retain a piece of DCVax-L and Direct can do so, from a place of greater security. Those who want out can exit.

The problem is that right now that and everything else is being held up by a journal article none of us asked for.
icon url

skitahoe

01/22/22 4:24 PM

#437796 RE: Maverick0408 #437788

Mav,

I believe that in a partnership with a BP the least the partner will get is one or two seats on the BOD. Frankly with a substantial ownership percentage and growing Institutional ownership, they would have a great deal of control of the company if they wished to force things to a vote.

I'm never concerned about the age of management or key people, changes can be made there without a buyout of the company. For all I know, if LP wished, after a BP partnership, she might very well step down from the CEO position, probably maintaining the position of Chairman of the Board, and that should be fine for her, and all concerned.

My point is that by remaining an independent company, they can grow far faster than by adding billions of additional sales revenue to a BP. I believe the increase in share price may very well provide more equity to a BP partner than the revenue they'd gain in owning the company. It's very possible that in such a partnership the BP would also gain a percentage of the product sales, and might very well become the distributor and marketer of the product as well.

I believe that LP and other key people at the company will do very well in such a partnership whether they remain working at the company, or choose to step down, my point isn't in keeping the specific staff together, but maintaining the company as an independently trading entity.

Gary